These results indicate an earlier onset of memory impairment and accelerated AD-like pathology in APP/ALDH2*2 OE mice with reduced activity of ALDH2 than in APP mice (Kanamaru et al., 2015). The gene discussed is ALDH2; the disease is memory impairment.